FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

VistaPharm NYSTATIN Oral Suspension Recall

NYSTATIN Oral Suspension, USP 500,000 Units/5mL, unit dose 5ml cups, packaged in a) 50…

VistaPharm, Inc. · Largo, FL

Risk level
Class III
Reported by FDA
Dec 26, 2018
Recall ID
D-0348-2019
Check your lot numberHow we source this data

Summary

VistaPharm recalled NYSTATIN Oral Suspension starting Nov 30, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0348-2019 on Dec 26, 2018. Reason: Failed Impurities/Degradation Specifications:Out of specification for impurities. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications:Out of specification for impurities.

Product description

NYSTATIN Oral Suspension, USP 500,000 Units/5mL, unit dose 5ml cups, packaged in a) 50 unit dose cups (10x5ml unit dose cups per tray, 5 trays per case) NDC 66689-037-50; b) 100 unit dose cups (10x5ml unit dose cups per tray, 10 trays per case) NDC 66689-037-99. Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771

Lot numbers, UPCs & expiration codes

Lots: a) 505300 Exp. Dec 2018; 522200 Exp. Apr 2019; 534400 Exp. Jul 2019; 539000 Exp. Aug 2019; 543400 Exp. Sep 2019; b) 523600, 522200X Exp. Apr 2019; 535500 Exp. Jul 2019; 540700 Exp. Aug 2019; 543300 Exp. Sep 2019; 550100 Exp. Oct 2019.

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0348-2019
Classification
Class III
Status
Terminated
Recall initiated
Nov 30, 2018
FDA report date
Dec 26, 2018
Quantity
4,065,550 5 ml cups
Recall type
Voluntary: Firm initiated
Recalling firm
VistaPharm, Inc.

Original FDA data

Every field from FDA enforcement report D-0348-2019, exactly as published.

Show all FDA fields
City
Largo
State
FL
Status
Terminated
Country
United States
Event ID
81684
Address
7265 Ulmerton Rd
Code information
Lots: a) 505300 Exp. Dec 2018; 522200 Exp. Apr 2019; 534400 Exp. Jul 2019; 539000 Exp. Aug 2019; 543400 Exp. Sep 2019; b) 523600, 522200X Exp. Apr 2019; 535500 Exp. Jul 2019; 540700 Exp. Aug 2019; 543300 Exp. Sep 2019; 550100 Exp. Oct 2019.
Postal code
33771-4809
Report date
Dec 26, 2018
Product type
Drugs
Recall number
D-0348-2019
Classification
Class III
Recalling firm
VistaPharm, Inc.
Product quantity
4,065,550 5 ml cups
Termination date
Nov 25, 2020
Reason for recall
Failed Impurities/Degradation Specifications:Out of specification for impurities.
Voluntary / mandated
Voluntary: Firm initiated
Product description
NYSTATIN Oral Suspension, USP 500,000 Units/5mL, unit dose 5ml cups, packaged in a) 50 unit dose cups (10x5ml unit dose cups per tray, 5 trays per case) NDC 66689-037-50; b) 100 unit dose cups (10x5ml unit dose cups per tray, 10 trays per case) NDC 66689-037-99. Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Nov 30, 2018
Initial firm notification
Letter
Center classification date
Jan 7, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0348-2019, published Dec 26, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls